Pre-IND CMC Checklist for Regulatory Success
At Ergomed Clinical Research, CMC strategy is more than a supporting function—it is a cornerstone of regulatory success.
Built on deep scientific expertise and decades of hands-on experience guiding products from discovery through first-in-human trials, our approach ensures development teams are prepared for every stage.
This Pre-IND CMC Checklist helps sponsors anticipate regulatory requirements early in development. It covers critical considerations such as defining quality attributes, ensuring raw material traceability, establishing robust banking systems, validating assays, and planning for long-term stability—all designed to set your program on the path to clinical and regulatory success.